Boston, MA -- (SBWIRE) -- 09/13/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (RealD (NYSE:RLD), Sandstorm Gold Ltd. Ordinary Shares (Canada) (NYSEAMEX:SAND), Tanzanian Royalty Exploration Corp. (US) (NYSEAMEX:TRX), Amarin Corporation plc (ADR) (NASDAQ:AMRN)
RealD (NYSE:RLD) shares dropped 8.86% and closed at $6.89. Analysts at B. Riley decreased their price objective on shares of RealD from $12.75 to $11.00 in a research report issued to clients and investors on Sept. 12. The firm currently has a “buy” rating on the stock. Separately, analysts at Stifel Nicolaus downgraded shares of RealD (NYSE:RLD) from a “buy” rating to a “hold” rating in a research note to investors on Wednesday, September 4th. They now have a $10.00 price target on the stock.
Is RLD A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Sandstorm Gold Ltd. Ordinary Shares (Canada) (NYSEAMEX:SAND) shares decreased 8.21% and closed at $5.37. The company on August 19 has amended the previously announced gold stream agreement (the "Amended Gold Stream") with Mutiny Gold Ltd. ("Mutiny") (MYG.AX). Mutiny is developing the Deflector project located in the Murchison Region of Western Australia ("Deflector").
In accordance with the Amended Gold Stream, Sandstorm has agreed to purchase an amount equal to 2.6% of the gold produced from Deflector in exchange for an upfront payment of US$6 million (the "Upfront Payment"). The Upfront Payment was previously remitted to Mutiny in the form of a loan, so there are no additional payments that are required to be made by Sandstorm.
Is SAND A Good Buy After The Recent Price Movement? Find Out Here
Tanzanian Royalty Exploration Corp. (US) (NYSEAMEX:TRX) shares dropped 8.09% and closed at $3.18 in the last trading session. The 52 week trading range for the company is $2.14 - $5.34. The company is a mineral resource company with exploration-stage properties, which engages in the acquisition of interests in and the exploration of natural resource properties. The Company’s main area of interest has been in the exploration of gold properties, with a primary focus on exploring for gold properties in Tanzania.
How Should Investors Trade TRX After The Recent Volatility? Get Free Report Here
Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock declined 7.35% to $6.67. The company, on Sept. 9, announced that it now has 30 patents issued or allowed by the United States Patent and Trademark Office (USPTO) related to its flagship product, Vascepa® (icosapent ethyl) capsules.
Amarin recently received Notices of Allowance for U.S. Patent Application Serial Numbers 13/777,398, 13/768,897, and 13/768,869, each titled "Stable Pharmaceutical Composition and Methods of Using Same." The scope of coverage related to Vascepa represented by these applications is the broadest allowed to date.
How Should Investors Trade AMRN After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)